Skip to main content
. Author manuscript; available in PMC: 2022 Sep 17.
Published in final edited form as: Circ Res. 2021 Aug 17;129(7):e121–e140. doi: 10.1161/CIRCRESAHA.121.318897

Figure 7. Inhibiting C3aR activity ameliorates O-exo–mediated detrimental effects in the aged ischemic brain.

Figure 7.

A. Confocal images showing Iba1 (green), CD68 (blue) and Homer1 (red) expression in the penumbra in aged ischemic rats treated with O-exo or a combination of O-exo and C3aR inhibitor (C3aRI). White arrows indicate Iba1+CD68+Homer1+ microglia. B. Quantification of Iba1+CD68+ activated microglia in aged ischemic rats 72 h after injection of O-exo with or without C3aRI (N = 5 per group). The P values were assessed by a Mann-Whitney test. C. Quantification of triple+ puncta per Iba1+ cells in the aged ischemic brain after injection of O-exo with and without C3aRI (N = 5 per group). The P values were assessed by a Mann-Whitney test. D, E. Quantification of total dendritic length (D), segments and branches and total spine length and segments (E) in the penumbra of aged ischemic rats 72 h after O-exo injection with or without C3aRI (N = 5 per group). The P values were assessed by a Mann-Whitney test. F. Representative CV-stained images showing infarct area in animals treated with O-exo alone or combination of O-exo and C3aRI. G. Infarct volume in aged ischemic rats treated with O-exo alone or combination of O-exo and C3aRI (N = 5 per group). The P values were assessed by a Mann-Whitney test. H. Sensorimotor deficits were determined by the ladder rung walking test in aged ischemic rats treated with O-exo alone or combination of O-exo and C3aRI. Data represent mean ± SEM. Each data point represents a biological replicate. The P values were assessed by unpaired Student’s t-test. O-exo, serum exosomes from aged rats.